Published in Heart Disease Weekly, March 27th, 2005
According to a study from the United States, "Infants undergoing surgery for congenital heart disease are at risk for myocardial ischemia during cardiopulmonary bypass, circulatory arrest, or low-flow states. The purpose of [our] study was to demonstrate the effects of sildenafil, a selective phospho-diesterase-5 (PDE-5) inhibitor on myocardial functional improvement and infarct size reduction during ischemia/reperfusion injury in infant rabbits."
Y.A. Bremer and colleagues of Virginia Commonwealth University described their study,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly